Caricamento...
Engineering yeast for producing human glycoproteins: where are we now?
Yeast has advanced as an alternative for mammalian cell culture for the production of recombinant therapeutic glycoproteins. Engineered yeast strains not only allow to mimic the human N-glycosylation pathway but also specific types of human O-glycosylation. This is of great value for therapeutic pro...
Salvato in:
| Pubblicato in: | Future Microbiol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7617146/ https://ncbi.nlm.nih.gov/pubmed/25598335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb.14.104 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|